lev-os Structuring CLO Reinvestment Periods
Designs CLO reinvestment criteria with portfolio quality tests, trading guidelines, and concentration limits.
When To Use
- Structuring or amending the reinvestment period for a new or refinanced CLO
- Defining portfolio quality tests (WARF, WAS, WAL, diversity score, minimum recovery rate)
- Drafting or reviewing trading guidelines that govern discretionary and credit-risk/credit-improved sales
- Setting concentration limits by obligor, industry, rating bucket, or asset type
- Evaluating manager flexibility versus investor protection trade-offs during reinvestment
- Comparing reinvestment criteria across a manager's CLO platform or against market benchmarks
Inputs To Gather
- Deal term sheet or indenture draft — reinvestment period length, non-call period, WAL test end date
- Target portfolio parameters — par amount, expected WARF, WAS, WAL, diversity score, recovery rate assumptions
- Rating agency methodology — Moody's, S&P, or Fitch CLO criteria in effect [VERIFY current version]
- Concentration limit schedule — maximum single obligor, industry (Moody's 33-industry or S&P classification), CCC bucket, second-lien/covenant-lite caps
- Trading flexibility provisions — discretionary sale baskets (percentage of principal balance), credit-risk and credit-improved definitions, reinvestment overcollateralization conditions
- Manager track record — historical turnover rates, default rates, par build/erosion across prior deals
- Market comparables — recent BSL CLO indentures from comparable managers for benchmarking
Workflow
Map the reinvestment timeline — Confirm reinvestment period start/end, non-call end, and any step-down or amortization trigger dates. Identify whether the deal includes a post-reinvestment trading period and its constraints.
Define portfolio quality tests — Specify each collateral quality test with its initial target and covenant level:
- Maximum WARF (e.g., 2850)
- Minimum WAS (e.g., 3.50%)
- Maximum WAL (e.g., 7.5 years declining to 4.0 by stated maturity)
- Minimum diversity score (e.g., 60)
- Minimum weighted-average recovery rate (e.g., 44.5%)
- Determine whether tests are measured at time of trade vs. time of settlement [VERIFY indenture convention]
Set concentration limits — Build the concentration schedule:
- Single obligor cap (typically 1.5%–2.0% of par)
- Industry concentration (Moody's 33-industry: max per industry, e.g., 10%–12%; aggregate top-3 cap) [VERIFY applicable industry classification]
- CCC-rated exposure cap (typically 7.5% par; excess haircut in OC tests)
- Second-lien, covenant-lite, DIP loan, and non-U.S. obligor sub-limits
- Fixed-rate asset cap and related hedge requirements
Draft trading guidelines — Define permissible reinvestment trades:
- Credit-risk sales — obligor downgraded below threshold or placed on watch-negative; no volume cap
- Credit-improved sales — obligor upgraded or spread tightened beyond threshold; often subject to annual basket (e.g., 20% of portfolio)
- Discretionary trades — subject to maintaining or improving all collateral quality tests post-trade
- Specify reinvestment criteria: acquired asset must satisfy eligibility criteria and not cause any quality test breach
Calibrate OC and IC coverage tests — Confirm overcollateralization and interest coverage trigger levels for each tranche and how reinvestment is restricted upon a test breach (e.g., diversion of interest proceeds to senior notes).
Benchmark against comparables — Compare proposed criteria to 3–5 recent deals from the same manager and 3–5 deals from peer managers. Flag any terms meaningfully tighter or looser than market.
Stress-test flexibility — Model scenarios (spread compression, credit deterioration, high default wave) to assess whether the reinvestment criteria provide sufficient manager flexibility without excessive par erosion risk.
Output
Produce a CLO Reinvestment Period Structuring Report containing:
- Reinvestment timeline summary — key dates, non-call/reinvestment/WAL test schedule
- Collateral quality test matrix — each test, its target level, covenant level, measurement convention, and cure mechanism
- Concentration limit schedule — tabular format with limit type, threshold, and haircut/excess treatment in OC tests
- Trading guidelines summary — permitted trade types, volume baskets, post-trade compliance requirements
- OC/IC test levels — per-tranche trigger and default levels with reinvestment lockout mechanics
- Comparable deal benchmarking table — side-by-side comparison of key reinvestment terms
- Manager flexibility assessment — qualitative view of how constraining the proposed terms are relative to market, with specific call-outs for atypical provisions
- Risk flags — any terms that may draw rating agency or investor pushback
Quality Checks
- All collateral quality tests reference the correct rating agency methodology version [VERIFY]
- Concentration limits are internally consistent (sub-limits do not exceed parent limits; aggregate caps are coherent)
- Trading guidelines clearly distinguish credit-risk, credit-improved, and discretionary buckets with no overlap or gap
- OC/IC trigger levels are consistent with the capital structure and rating agency required subordination
- WAL test step-down schedule aligns with expected portfolio amortization profile
- Benchmarking uses deals from the same vintage (within 12 months) and comparable portfolio type (BSL vs. MM)
- No quality test is set at a level that would be immediately breached by the target portfolio
- All dollar and percentage thresholds are expressed on a consistent basis (par amount vs. aggregate principal balance)